Alembic Pharma shares gained attention on Wednesday after the company announced that it had received tentative approval from the United States Food and Drug Administration (USFDA) for Darolutamide Tablets 300 mg, a treatment used for prostate cancer.
Dr Reddy’s Laboratories is expanding its semaglutide generic franchise while trimming parts of its oncology pipeline as the company sharpens its focus on the fast-growing obesity treatment market and diabetes care segment.
SwishX, a Bengaluru-based startup backed by $2.2M in seed funding, launches the world's first agentic AI platform to modernise pharma and medtech sales, marketing, and distribution across a $400 billion emerging market opportunity.
Abbott has launched its TriClip TEER system in India, bringing a new minimally invasive treatment option for patients suffering from tricuspid regurgitation, a serious heart valve disorder caused by a leaking tricuspid valve.
The pharmaceutical outsourcing landscape has changed dramatically in recent years, making the search for the Right CDMO in India a far more strategic decision than ever before. In 2026, selecting a Contract Development and Manufacturing...
Emami acquires IncNut in a Rs 321 crore deal aimed at expanding its presence in India’s growing digital beauty and personal care market. The FMCG company announced today that it will purchase a 60 percent stake in Hyderabad-based IncNut Digital...
India’s nerve care market sees shift to targeted OTC solutions as P&G Health launches Neurobion cream with capsaicin-based formula for effective nerve pain relief.
In an era where healthcare is rapidly shifting from treatment to prevention, Harish Reddy, Managing Director & CEO of SD Lifesciences India., stands at the forefront of India’s wellness transformation. His journey is deeply rooted in a belief that...
Mounjaro has officially overtaken Merck’s Keytruda to become the world’s best-selling drug, marking a major shift in the global pharmaceutical market. The blockbuster diabetes treatment from Eli Lilly & Co. generated USD 8.7 billion in sales...
Ajanta Pharma reported strong growth in its Ajanta Pharma Q4 results, with both domestic and global businesses driving performance for the quarter ended March 31, 2026. Revenue from operations rose 21 percent year-on-year to Rs 1,422 crore...
, CDSCO.jpg)